Finally, it is also worth highlighting how HRV moderately predicts ALS patient functionality (r = 0.21) (measured by the ALSFRS-R test) independently of PON1 activity and the rest of the variables analyzed (Figure 1). The gene discussed is PON1; the disease is amyotrophic lateral sclerosis.